UBS Group’s Immunovant, Inc. Units IMVTU Stock Holding History

UBS Group’s Portfolio IMVTU Stock Details IMVTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-772	Closed	-$13K	–	8671
2020 Q1	$13K	Sell	772 -307	-28%	-$5.93K	﹤0.01%	6802
2019 Q4	$26K	Buy	+1,079	New	+$23.2K	﹤0.01%	6743

UBS Group's IMVTU Position: Q2 2020 in Review

UBS Group sold out of Immunovant, Inc. Units (IMVTU) in Q2 2020, closing a stake of 772 shares — an estimated $13K sold.

UBS Group first reported a position in IMVTU in Q4 2019 and held it in 2 quarters. The position peaked at $26K in Q4 2019. 0 funds tracked by Wall St. Rank hold IMVTU as of Q2 2020.

UBS Group reported no remaining Immunovant, Inc. Units position as of Q2 2020 after selling out during the quarter.
UBS Group sold 772 Immunovant, Inc. Units shares in Q2 2020, an estimated $13K.
UBS Group first reported a position in Immunovant, Inc. Units in Q4 2019 and held it in 2 quarters.
UBS Group's Immunovant, Inc. Units position peaked at $26K in Q4 2019.
0 funds tracked by Wall St. Rank held Immunovant, Inc. Units as of Q2 2020.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.